Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
Clinical trial NCT02619617 · TERMINATED
Trial details
- NCT number
- NCT02619617
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-31
- Primary completion
- 2018-09-25
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.